Marketing-authorisation holder · Canada
Generic Medical Partners Inc
52 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
52 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 52
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AZITHROMYCIN FOR INJECTION500 mg / vial · Powder For Solution | Azithromycin | Canada | Marketed | 2023 |
| BORTEZOMIB FOR INJECTION3.5 mg / vial · Powder For Solution | Bortezomib | Canada | Authorised | |
| CLADRIBINE INJECTION1 mg / ml · Solution | Cladribine | Canada | Marketed | 2020 |
| DAUNORUBICIN INJECTABLE SOLUTION50 mg / 10 ml · Solution | Daunorubicin | Canada | Marketed | 2026 |
| DAUNORUBICIN INJECTABLE SOLUTION20 mg / 4 ml · Solution | Daunorubicin | Canada | Authorised | |
| FLUOROURACIL INJECTION5000 mg / 100 ml · Solution | Fluorouracil | Canada | Authorised | |
| FLUOROURACIL INJECTION500 mg / 10 ml · Solution | Fluorouracil | Canada | Authorised | |
| FLUOROURACIL INJECTION1000 mg / 20 ml · Solution | Fluorouracil | Canada | Authorised | |
| FLUOROURACIL INJECTION250 mg / 5 ml · Solution | Fluorouracil | Canada | Authorised | |
| GEMCITABINE FOR INJECTION USP200 mg / vial · Powder For Solution | Gemcitabine | Canada | Authorised | |
| GEMCITABINE FOR INJECTION USP1 g / vial · Powder For Solution | Gemcitabine | Canada | Authorised | |
| IRINOTECAN HYDROCHLORIDE INJECTION, USP20 mg / ml · Solution | Irinotecan | Canada | Marketed | 2024 |
| LEUCOVORIN CALCIUM INJECTION1000 mg / 100 ml · Solution | Calcium folinate | Canada | Marketed | 2021 |
| LEUCOVORIN CALCIUM INJECTION10 mg / ml · Solution | Calcium folinate | Canada | Marketed | 2019 |
| LEUCOVORIN CALCIUM INJECTION200 mg / 20 ml · Solution | Calcium folinate | Canada | Authorised | |
| MED-ANASTROZOLE1 mg · Tablet | Anastrozole | Canada | Not marketed | 2012 |
| MED-BICALUTAMIDE50 mg · Tablet | Bicalutamide | Canada | Authorised | |
| MED-BRIMONIDINE0.2 % / w/v · Solution | Brimonidine | Canada | Marketed | 2021 |
| MED-CLINDAMYCIN150 mg · Capsule | Clindamycin | Canada | Marketed | 2021 |
| MED-CLINDAMYCIN300 mg · Capsule | Clindamycin | Canada | Marketed | 2021 |
| MED-CYPROTERONE50 mg · Tablet | Cyproterone | Canada | Marketed | 2012 |
| MED-DORZOLAMIDE2 % / w/v · Solution | Dorzolamide | Canada | Marketed | 2023 |
| MED-DORZOLAMIDE-TIMOLOL20 mg / ml + 5 mg / ml · Solution | Dorzolamide, Timolol | Canada | Marketed | 2016 |
| MED-DUTASTERIDE0.5 mg · Capsule | Dutasteride | Canada | Not marketed | 2014 |
| MED-EXEMESTANE25 mg · Tablet | Exemestane | Canada | Marketed | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 52 | 52 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.